Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl
Preferences help
Polish version English version Language
enabled [disable] Abstract
Number of results

Results found: 3

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
1
Content available remote

Wykorzystanie osadu czynnego w oczyszczaniu ścieków

100%
Lenart A., Kowalska A.
Kosmos
|
2012
|
vol. 61
|
issue 4
677-689
PL
W pracy opisano mechanizm biologicznego oczyszczania ścieków metodą osadu czynnego. Opisane zostały cechy oraz rola głównych grup mikroorganizmów wchodzących w skład osadu. Przedstawiony został schemat i mechanizmy usuwania poszczególnych rodzajów zanieczyszczeń w miejskiej oczyszczalni ścieków z wykorzystaniem metody osadu czynnego. Opisane zostało zastosowanie powyższej metody w przydomowych oczyszczalniach oraz sposoby postępowania z powstałym w wyniku procesu oczyszczania osadem nadmiernym.
EN
The study describes biological wastewater treatment method using activated sludge. It presents the features and the role of major groups of microorganisms included in the sludge. Additionally, a scheme and mechanisms of removal of various pollutants in municipal wastewater treatment plant using activated sludge method were presented. The study describes the application of this method in domestic sewage treatment, and the ways of dealing with excess sludge resulting from the treatment process.
2
Content available remote

Application of electrophoretic methods for detection of protein-porphyrin complexes.

61%
Kowalska A., Kwiek P., Miłosz E., Gondek G., Romiszewska A., Graczyk A., Podhajska A. J.
|
2003
|
vol. 50
|
issue 4
1155-1163
EN
Simple methods for detection and isolation of protein-porphyrin complexes were elaborated in our laboratory. They are based on the separation of protein-porphyrin complexes in native polyacrylamide gel and measurement of their fluorescence, with the use of two detection systems: the commercially available Gel DocTM 2000 system, and a system specially designed for the purpose of these investigations, concerning protein-porphyrin interactions. The fluorescent complexes can be electro-transferred from the gel onto PVDF membrane, eluted and analyzed in order to identify the protein interacting with porphyrins.
3
Content available remote

Association between concentration of melatonin, and lipoproteins, LPO, hsCRP, NTproBNP in chronic heart failure patients

52%
Kimak E., Dzida G., Duma D., Prystupa A., Halabis M., Kimak A., Zieba B., Kaznowska-Bystryk I., Kowalska A.
Current Issues in Pharmacy and Medical Sciences
|
2014
|
vol. 27
|
issue 3
159-164
EN
The aim of the study was to examine concentrations and relationships between melatonin levels assessed at 0:200 hrs and 0:700 hrs, lipid hydroperoxide (LPO) assessed at 0:200 hrs and 0:700 hrs, and apolipoprotein (apo)AI, apoAII, apoB, high sensitivity C-reactive protein (hsCRP) and NT-proBNP, in 27 patients with chronic heart failure (CHF) (17 patients - with NYHA class II and 10 - with NYHA class III). In the study, Lipoproteins apoAI, apoAII, apoB, high sensitivity C-reactive protein (hsCRP) levels were determined by way of immunonephelometric methods, serum melatonin concentration was measured by using a competitive enzyme immunoassay technique, while serum LPO concentration was measured by using Cayman’s Lipid Hydroperoxide Assay Kit. In the study, CHF patients without acute inflammatory response demonstrated a decreased concentration of high density lipoprotein cholesterol (HDL-C), apoAI, apoAII levels, but an increased concentration of NT-proBNP, hsCRP and LPO at night, and LPO at daytime; however, the concentration of LPO at 0:700 was lower than at 0:200. Pearson’s correlation test and multiple ridge stepwise regression showed that melatonin administered at night exerts an effect on the composition of apoAI and apoAII of HDL particles, and induces decreased LPO at 0:700, but has no effect upon NT-proBNP levels in patients with NYHA class II. However, in patients with NYHA class III, melatonin administered at night induces an increase in the content of apoAII and apoAI, which further decreases hsCRP, and this, together with the administered melatonin, brings about daytime decreases in NT-proBNP and hsCRP levels. The results indicated that the content of apoAII and apoAI in HDL particles and melatonin demonstrate an anti-oxidative and anti-inflammatory effect, and together, have a cardio-protective effect on patients with advanced CHF. Hence, the results support melatonin being a cardio-protective agent. These relationships, however, need to be confirmed in further studies.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.